Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$25.38
0.0%
$24.64
$15.73
▼
$30.00
$13.14B0.687.06 million shs4.32 million shs
Glaukos Corporation stock logo
GKOS
Glaukos
$237.24
-0.4%
$190.92
$93.78
▼
$255.18
$14.05B0.681.91 million shs1.09 million shs
LivaNova PLC stock logo
LIVN
LivaNova
$90.74
-1.4%
$81.60
$53.48
▼
$99.38
$5.00B0.91823,240 shs536,657 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$101.22
-0.2%
$96.50
$79.12
▼
$112.54
$19.13B0.52.64 million shs2.96 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
0.00%-1.52%-1.21%-3.75%+43.35%
Glaukos Corporation stock logo
GKOS
Glaukos
0.00%-3.40%+34.07%+27.78%+145.72%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-0.63%+11.66%+15.25%+68.32%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.00%-1.91%+2.42%+0.21%+13.09%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$25.38
0.0%
$24.64
$15.73
▼
$30.00
$13.14B0.687.06 million shs4.32 million shs
Glaukos Corporation stock logo
GKOS
Glaukos
$237.24
-0.4%
$190.92
$93.78
▼
$255.18
$14.05B0.681.91 million shs1.09 million shs
LivaNova PLC stock logo
LIVN
LivaNova
$90.74
-1.4%
$81.60
$53.48
▼
$99.38
$5.00B0.91823,240 shs536,657 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$101.22
-0.2%
$96.50
$79.12
▼
$112.54
$19.13B0.52.64 million shs2.96 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
0.00%-1.52%-1.21%-3.75%+43.35%
Glaukos Corporation stock logo
GKOS
Glaukos
0.00%-3.40%+34.07%+27.78%+145.72%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%-0.63%+11.66%+15.25%+68.32%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.00%-1.91%+2.42%+0.21%+13.09%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
1.86
Reduce$23.27-8.30% Downside
Glaukos Corporation stock logo
GKOS
Glaukos
2.88
Moderate Buy$218.00-8.11% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.75
Moderate Buy$101.2211.55% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.29
Hold$114.3212.94% Upside

Current Analyst Ratings Breakdown

Latest LIVN, ZBH, GKOS, and BAX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/17/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
UpgradeEqual Weight ➝ Overweight$113.00 ➝ $123.00
11/16/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$234.00 ➝ $252.00
11/16/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Lower Price TargetMarket Perform$102.00 ➝ $101.00
11/16/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetBuy$125.00 ➝ $140.00
11/9/2026
Baxter International Inc. stock logo
BAX
Baxter International
Boost Price TargetUnderweight$20.00 ➝ $23.00
11/9/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetOverweight$105.00 ➝ $120.00
11/9/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetEqual Weight$100.00 ➝ $115.00
11/5/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Set Price Target$114.00
11/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetOutperform$95.00 ➝ $111.00
11/5/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetBuy$120.00 ➝ $130.00
11/5/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetNeutral$117.00 ➝ $120.00
(Data available from 11/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$11.24B1.17$5.68 per share4.47$12.52 per share2.03
Glaukos Corporation stock logo
GKOS
Glaukos
$507.44M27.68N/AN/A$12.12 per share19.57
LivaNova PLC stock logo
LIVN
LivaNova
$1.51B3.32$4.84 per share18.76$24.91 per share3.64
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$8.23B2.33$13.75 per share7.36$67.24 per share1.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$957M-$1.41N/A12.503.73-6.23%16.23%5.08%N/A
Glaukos Corporation stock logo
GKOS
Glaukos
-$187.69M-$2.94N/A143.78N/A-24.60%-0.97%-0.71%N/A
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.0030.2521.50N/A13.01%16.10%7.85%N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$705.20M$3.9525.6211.372.378.95%13.02%7.17%2/9/2027 (Estimated)

Latest LIVN, ZBH, GKOS, and BAX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.06$1.23+$0.17$0.11$381.14 million$393.15 million
11/4/2026Q3 2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.88$1.90+$0.02$1.00$2.04 billion$2.06 billion
10/29/2026Q3 2026
Baxter International Inc. stock logo
BAX
Baxter International
$0.5180$0.58+$0.0620$0.57$2.91 billion$2.98 billion
10/28/2026Q3 2026
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.0964$0.47+$0.5664$0.03$168.04 million$211.03 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.040.16%-11.54%N/A N/A
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.95%N/A24.30%N/A

Latest LIVN, ZBH, GKOS, and BAX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/28/2026
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.010.17%11/27/202611/27/20261/4/2027
8/28/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.08%9/30/20269/30/202610/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.20
1.79
1.19
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
4.57
4.09
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.46
1.22
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.49
1.46
0.79

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.17%
Glaukos Corporation stock logo
GKOS
Glaukos
5.90%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
1.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
37,500517.35 million516.47 millionOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
1,09459.20 million55.70 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.89 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000189.25 million186.83 millionOptionable

Recent News About These Companies

Zimmer Biomet: Fixing Its Own House While Its Rivals Are Distracted
Zimmer Biomet: Solid Sales And Cash Flow Drive A Buy
Can Zimmer Biomet Holdings (ZBH) Stay Cheap If Cash Flow Delivers?
Zimmer Biomet (NYSE:ZBH) Stock Rating Upgraded by Wells Fargo & Company
Zimmer Biomet (ZBH) PT Raised to $140 at Stifel
Zimmer Biomet (NYSE:ZBH) Stock Rating Raised to Buy at Wall Street Zen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Baxter International stock logo

Baxter International NYSE:BAX

$25.38 -0.01 (-0.04%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$25.38 0.00 (0.00%)
As of 11/20/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Glaukos stock logo

Glaukos NYSE:GKOS

$237.24 -0.86 (-0.36%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$237.30 +0.05 (+0.02%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$90.74 -1.33 (-1.44%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$90.72 -0.02 (-0.03%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$101.22 -0.25 (-0.25%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$100.98 -0.24 (-0.24%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.